|
TBL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.78359999999778E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.564940E-04 |
| Normal-vs-Stage2 |
6.642600E-01 |
| Normal-vs-Stage3 |
1.17190000037404E-07 |
| Normal-vs-Stage4 |
1.08050000002802E-06 |
| Stage1-vs-Stage2 |
3.113600E-02 |
| Stage1-vs-Stage3 |
3.690200E-02 |
| Stage1-vs-Stage4 |
4.444300E-02 |
| Stage2-vs-Stage3 |
2.062400E-03 |
| Stage2-vs-Stage4 |
1.580510E-03 |
| Stage3-vs-Stage4 |
6.461200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.72690000000264E-05 |
| Normal-vs-AfricanAmerican |
2.223700E-02 |
| Normal-vs-Asian |
4.89329999997512E-06 |
| Caucasian-vs-AfricanAmerican |
7.177200E-01 |
| Caucasian-vs-Asian |
3.247600E-01 |
| AfricanAmerican-vs-Asian |
4.174800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07489999999311E-05 |
| Normal-vs-Female |
2.171300E-04 |
| Male-vs-Female |
2.380000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.415900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.002400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.239520E-04 |
| Normal-vs-Age(81-100Yrs) |
6.525900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.125800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.511000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.632400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.970000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.941000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.594800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.24349999996998E-06 |
| Classical-VS-Follicular |
3.273000E-01 |
| Classical-VS-Other |
7.673900E-02 |
| Classical-VS-Normal |
8.20400000000054E-05 |
| Tall-VS-Follicular |
1.94221999999522E-05 |
| Tall-VS-Other |
9.489800E-01 |
| Tall-VS-Normal |
8.18249912271085E-11 |
| Follicular-VS-Other |
1.180610E-01 |
| Follicular-VS-Normal |
2.763700E-02 |
| Other-VS-Normal |
1.537620E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.484700E-03 |
| Normal-vs-N1 |
2.50300002946346E-09 |
| N0-vs-N1 |
4.46489999994526E-06 |
|
|
